Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Torisel (temsirolimus) Important Safety Information from Wyeth following approval by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
06/01/2009
Problem Or Issue:
Please find attached safety communication from Wyeth in respect of timing and monitoring for infusion/hypersensitivity reactions associated with the administration of TORISEL 25mg/ml concentrate and diluent for solution for infusion.
Imporant Safety Information - Torisel (temsirolimus)
« Back
Date Printed: 05/05/2024